Ginwa Enterprise Group Inc (600080) fair value: what the stock is really worth
As of Sep 24, 2026: fair value of Ginwa Enterprise Group Inc ¥0.76, price ¥4.73, upside -83.9%, quality 45 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Ginwa Enterprise Group Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range ¥4.41 – ¥10.87 · fair‑value band ¥0.5300 – ¥0.9900 · the ¥4.73 price screens above the ¥0.7600 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. Dashed = 300-day average. As of Sep 24, 2026.
Follow Ginwa Enterprise Group in your weekly email
Every Wednesday you see whether Ginwa Enterprise Group is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Ginwa Enterprise (Group) Inc. researches, develops, produces, markets, and sells traditional Chinese medicines, biological drugs, and chemical drugs primarily in China.
Show more
Ginwa Enterprise (Group) Inc. researches, develops, produces, markets, and sells traditional Chinese medicines, biological drugs, and chemical drugs primarily in China. The company offers a range of orthopaedics, immunity, children, and general medicines in various dosage forms, including tablets, capsules, granules, powders, mixtures, oral solutions, syrups, and external solutions. It is also involved in the pharmaceutical logistics activities. The company was founded in 1996 and is headquartered in Xi'an, China.
Stock analysis
Ginwa Enterprise Group Inc (600080) currently trades at ¥4.73, while our model-based Fair Value estimate is ¥0.7600, implying the stock looks roughly 522.3% overvalued today.
Show more
Valuation
Bull case: the Asset-Based group reads highest at a median of ¥2.80 per share, and 0 of the 15 models we run sit above the ¥4.73 price.
Bear case: the Dividend Discount group reads lowest at ¥0.3500, and 15 of the 15 models stay below the price. Evidence for this calculation is low.
Scenario range: ¥0.5300 (bear) to ¥0.9900 (bull), the price of ¥4.73 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 45/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Ginwa Enterprise Group Inc reported revenue of 544M CNY in FY2025 versus 534M CNY in FY2021, a compound +0.5%/yr. Reported net income was 15.6M CNY in FY2025.
Key figures
Market cap 1.8B CNY (≈ $263M) · P/E ratio 94.6 · P/S ratio 2.71 · EPS (TTM) ¥0.0500 · Dividend yield 0.6% · Net margin 2.9% · Return on equity 1.1% · Return on assets (EBIT) 0.9%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (medium confidence).
What moves the price
The share trades about 48% below its 52-week high and 7% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −8% fair-value upside, at −84%, 600080 screens richer than that median.
Fair Value models
The price assumes far more growth than our models allow for, so the models scatter widely (¥0.1900 to ¥2.80). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear ¥0.5300Fair Value ¥0.7600Bull ¥0.9900
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (¥0.0147 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.8/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−7.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−2.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−4.0%
Start year 2020 (pandemic). Over 10 years: −2.9% a year
Revenue growth 31 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.4%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−13.5%
Earnings growth per share plus dividend.
Earnings per share, growth per year−14.1%
Dividend (yield on the price)0.6%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−14% vs −7%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.7% → 1%
Start year 2020 (pandemic)
⚠ Revenue per share shrinking 4.2%/yr over ~10Y (margins eroding too) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Compare Ginwa Enterprise Group Inc with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 629 stocks
Beats the industry median on 3/13 measures
Overall it trails its industry peers.
Valuation
Quality Score45 · Below median
Fair Value upside−84% · Bottom 25%
Profitability
Return on equity (TTM)1% · Below median
Return on assets0% · Below median
Net margin (TTM)3% · Below median
Operating margin (TTM)8% · Below median
Growth and dividend
Revenue growth18% · Top 25%
Dividend yield (TTM)0.6% · Below median
Balance sheet
Debt / equity0.03× · Below median
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
P/E (TTM)94.6× · Priciest 25%
P/B1.13× · Cheaper than median
P/S (TTM)3.13× · Pricier than median
EV/EBITDA63.9× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 15
FUTURE (revenue growth)92· sector 20
PAST (return on equity)5· sector 27
HEALTH (low debt)98· sector 96
DIVIDEND (yield)13· sector 32
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Ginwa Enterprise Group Inc Fair Value". https://www.fairvalue-calculator.com/stock/600080
Frequently asked questions
Is Ginwa Enterprise Group Inc (600080) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of ¥0.7600 versus a price of ¥4.73, about −84% upside (overvalued).
What is the fair value of 600080?
Our model-based fair value for Ginwa Enterprise Group Inc is ¥0.7600 (as of Sep 24, 2026), built from audited fundamentals. The current price: ¥4.73.
What is the quality score of 600080?
Ginwa Enterprise Group Inc has a Quality Score of 45/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Ginwa Enterprise Group Inc (600080)?
Our model-based price target is the fair value of ¥0.7600 (as of Sep 24, 2026) from 15 valuation models. Cautious scenario ¥0.5300, optimistic scenario ¥0.9900. It is a calculation from audited fundamentals, not an analyst target.
What is the Ginwa Enterprise Group Inc stock forecast for 2026?
Our models put fair value at ¥0.7600, about −84% upside versus a price of ¥4.73 (overvalued). Cautious scenario ¥0.5300, optimistic scenario ¥0.9900. The calculation is refreshed regularly with new filings.
What is the revenue of Ginwa Enterprise Group Inc (600080)?
Ginwa Enterprise Group Inc reported trailing-twelve-month revenue of about 564M CNY (latest available figure, as of Sep 24, 2026).
Does Ginwa Enterprise Group Inc pay a dividend?
Ginwa Enterprise Group Inc currently shows a dividend yield of about 0.63% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of Ginwa Enterprise Group Inc (600080)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Ginwa Enterprise Group Inc it is ¥0.7600 per share (as of Sep 24, 2026), against a price of ¥4.73. It is the blended result of 15 valuation models (cash flow, earnings, asset, dividend).
Is Ginwa Enterprise Group Inc stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 600080 trades above its calculated fair value: price ¥4.73, fair value ¥0.7600, a gap of about −84% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 600080?
No. The price is what the market pays today (¥4.73); the fair value is what the company's own numbers justify (¥0.7600). For Ginwa Enterprise Group Inc the two are ¥3.97 per share apart. That gap is exactly why we show both numbers side by side.
How much is Ginwa Enterprise Group Inc worth?
The market values Ginwa Enterprise Group Inc at about 1.8B CNY (market capitalisation, as of Sep 24, 2026). Per share that is ¥4.73; our models calculate a fair value of ¥0.7600 per share.
What do the bullish and bearish scenarios say about 600080?
Our models span a range for Ginwa Enterprise Group Inc: cautious scenario ¥0.5300, base ¥0.7600, optimistic ¥0.9900 per share (as of Sep 24, 2026, price ¥4.73). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 600080?
Ginwa Enterprise Group Inc trades at a price-to-earnings ratio of 94.6 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ¥0.7600 is built from several models across several years. Other multiples: P/B 1.1, P/S 3.1, EV/EBITDA 63.9.
How solid is the balance sheet of Ginwa Enterprise Group Inc (600080)?
Balance-sheet figures for Ginwa Enterprise Group Inc (as of Sep 24, 2026): return on equity 1.1%, debt of 0.03 per unit of equity. They feed the Quality Score of 45/100, which measures business quality independently of the share price.
How far is 600080 from its 52-week high?
Ginwa Enterprise Group Inc trades at ¥4.73, about 48% below its 52-week high of ¥9.16 and 7% above the low of ¥4.41 (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of ¥0.7600 is for.
Which stocks are comparable to Ginwa Enterprise Group Inc?
From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Jiangsu Hengrui Pharmaceuticals Co, Sun Pharmaceutical Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Ginwa Enterprise Group Inc stock attractive at the current price?
The data as of Sep 24, 2026: price ¥4.73, calculated fair value ¥0.7600 (−84%), Quality Score 45/100, from 15 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 600080 calculated?
We run Ginwa Enterprise Group Inc through 15 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ¥0.7600, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0 % above its aggregate fair value. Ginwa Enterprise Group Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Ginwa Enterprise Group Inc (600080)?
The closing price on Sep 24, 2026 was ¥4.73. Our model-based fair value is ¥0.7600, about −84% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Ginwa Enterprise Group Inc right now?
The price sits above even our optimistic bull case (¥0.9900). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (45/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (¥0.5300 to ¥0.9900) leaves room in how you read the outcome.
Key figures of Ginwa Enterprise Group Inc
How large is the market capitalisation of Ginwa Enterprise Group Inc (600080)?
The market capitalisation of Ginwa Enterprise Group Inc is 1.8B CNY (≈ $263M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Ginwa Enterprise Group Inc (600080)?
The price-to-sales ratio of Ginwa Enterprise Group Inc is 2.71 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Ginwa Enterprise Group Inc (600080)?
Earnings per share at Ginwa Enterprise Group Inc are ¥0.0500 (price ÷ EPS = P/E 94.6). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Ginwa Enterprise Group Inc (600080)?
The dividend yield of Ginwa Enterprise Group Inc is 0.6% (payout 60.0%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Ginwa Enterprise Group Inc (600080)?
The net margin of Ginwa Enterprise Group Inc is 2.9% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Ginwa Enterprise Group Inc (600080)?
The return on equity (ROE) of Ginwa Enterprise Group Inc is 1.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Ginwa Enterprise Group Inc (600080)?
On an EBIT basis the return on assets of Ginwa Enterprise Group Inc is 0.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Ginwa Enterprise Group Inc (600080)?
The operating margin of Ginwa Enterprise Group Inc is 8.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Ginwa Enterprise Group Inc (600080)?
Revenue at Ginwa Enterprise Group Inc is growing +18.3% versus a year earlier (3y avg −2.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Ginwa Enterprise Group Inc (600080)?
Earnings per share at Ginwa Enterprise Group Inc are growing +224% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Ginwa Enterprise Group Inc (600080) generate?
The free cash flow of Ginwa Enterprise Group Inc is −100M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Ginwa Enterprise Group Inc (600080) hold?
Ginwa Enterprise Group Inc holds more cash than debt, 304M CNY net (fiscal year 2024). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Ginwa Enterprise Group Inc in the live analysis
One click puts Ginwa Enterprise Group Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
